Legal Issues
Plaintiff drops Vioxx suit against Merck five weeks before trial in Philadelphia
Published in Health Risk Factor Week, February 20th, 2007
The case was selected for trial by plaintiff's counsel and would have been the first Vioxx case to go to trial in Philadelphia.
"We believe that our evidence was strong in this case and Merck was prepared to go forward with the trial," said Ted Mayer of Hughes Hubbard & Reed, Merck's outside counsel.
In this case, Angela McCool alleged that Vioxx caused her husband's heart...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Aspergillosis Therapy
Research conducted at National Institutes of Health has provided new information about aspergillosis therapy - Bacterial Meningitis Epidemiology
Investigators at University of Amsterdam, Center of Infection and Immunity Amsterdam release new data on bacterial meningitis epidemiology - Bioterrorism
Reports from Israel Center for Disease Control highlight recent research in bioterrorism - Bioterrorism
Research on bioterrorism in children discussed by scientists at Stony Brook University - Bird Flu
Reports summarize bird flu research from University of Georgia, College of Veterinary Medicine - Bird Flu Genetics
Research findings from National Chung-Hsing University, Department of Veterinary Medicine update understanding of bird flu genetics - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
